Combination of human leukocyte antigen and killer cell immunoglobulin-like receptor genetic background influences the onset age of hepatocellular carcinoma in male patients with hepatitis B virus infection.
Combination of human leukocyte antigen and killer cell immunoglobulin-like receptor genetic background influences the onset age of hepatocellular carcinoma in male patients with hepatitis B virus infection.
复制标题
人白细胞抗原与杀伤细胞免疫球蛋白样受体遗传背景的组合影响乙型肝炎病毒感染男性患者肝细胞癌的发病年龄
DOI:
10.1155/2013/874514
复制
发表时间:
2013
影响因子:
--
通讯作者:
Zhang J
中科院分区:
文献类型:
--
作者:
Pan N;Qiu J;Sun H;Miao F;Shi Q;Xu J;Jiang W;Jin H;Xie W;He Y;Zhang J
To investigate whether killer cell immunoglobulin-like receptor (KIR) and human leukocyte antigen (HLA) genetic background could influence the onset age of hepatocellular carcinoma (HCC) in patients with hepatitis B virus (HBV) infection, one hundred and seventy-one males with HBV-related HCC were enrolled. The presence of 12 loci of KIR was detected individually. HLA-A, -B, and -C loci were genotyped with high resolution by a routine sequence-based typing method. The effect of each KIR locus, HLA ligand, and HLA-KIR combination was examined individually by Kaplan-Meier (KM) analysis. Multivariate Cox hazard regression model was also applied. We identified C1C1-KIR2DS2/2DL2 as an independent risk factor for earlier onset age of HCC (median onset age was 44 for C1C1-KIR2DS2/2DL2 positive patients compared to 50 for negative patients, P = 0.04 for KM analysis; HR = 1.70, P = 0.004 for multivariate Cox model). We conclude that KIR and HLA genetic background can influence the onset age of HCC in male patients with HBV infection. This study may be useful to improve the current HCC surveillance program in HBV-infected patients. Our findings also suggest an important role of natural killer cells (or other KIR-expressing cells) in the progress of HBV-related HCC development.
登录
查看更多内容
影响因子:
120.7
作者:
Chen, CJ;Yang, HI;Iloeje, UH
通讯作者:
Iloeje, UH
影响因子:
--
作者:
Hong HA;Loubser AS;de Assis Rosa D;Naranbhai V;Carr W;Paximadis M;Lewis DA;Tiemessen CT;Gray CM
通讯作者:
Gray CM
影响因子:
4.4
作者:
Foley, Bree;De Santis, Dianne;Witt, Campbell
通讯作者:
Witt, Campbell
DOI:
10.1084/jem.20061287
发表时间:
2007-03-19
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Dunn C;Brunetto M;Reynolds G;Christophides T;Kennedy PT;Lampertico P;Das A;Lopes AR;Borrow P;Williams K;Humphreys E;Afford S;Adams DH;Bertoletti A;Maini MK
通讯作者:
Maini MK
DOI:
10.1084/jem.181.3.1133
发表时间:
1995-03-01
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Gumperz JE;Litwin V;Phillips JH;Lanier LL;Parham P
通讯作者:
Parham P